protein

Recombinant Human Angiopoietin-like 3 (aa 17-220), CF

4954-AN-050

50 ug

404 USD

4954-AN

4954-AN-050

Recombinant Human Angiopoietin-like 3 (aa 17-220), CF

The Recombinant Human Angiopoietin-like 3 (aa 17-220), CF from R&D Systems is derived from CHO. The Recombinant Human Angiopoietin-like 3 (aa 17-220), CF has been validated for the following applications: Inhibition Activity.

Angiopoietin-like Protein 3/ANGPTL3

50 ug

Proteins and Enzymes

Lyophilized from a 0.2 µm filtered solution in PBS and NaCl.

Unconjugated

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Human

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.

35-43 kDa, reducing conditions

24.6 kDa

ANGPTL3

Measured by its ability to inhibit lipoprotein lipase activity. Yoshida, K. et al . (2002) J. Lipid Res. 43 :1770. The IC50 value under conditions in which Recombinant Human Lipoprotein Lipase/LPL (Catalog # 9888-LL ) and p-nitrophenyl butyrate are present in 0.1 M Sodium Phosphate, 0.15 M NaCl, 0.5% Triton® X-100, pH 7.2, is approximately 15 µg/mL.

<0.10 EU per 1 µg of the protein by the LAL method.

Q9Y5C1

Inhibition Activity

4954-AN, rhANGPTL3 aa 17-220, hANGPTL3, carrier-free, carrier free, 4954AN, cytokinegrowthfact, Angiopoietin like Protein 3, Angiopoietin like 3, Angiopoietin-like 3, Angiopoietinlike3, Angiopoietin 5, ANGPTL 3, Angiopoetin like 3,

CHO-derived Recombinant Human Angiopoietin-like 3 (aa 17-220), CF

396

404 USD

AGNPT5, Ang-5, angiopoietin 5, Angiopoietin-5, angiopoietin-like 3, Angiopoietin-like protein 3, angiopoietin-related protein 3, ANGPT5angiopoietin-5, ANGPTL3, FHBL2